Peyto Exploration&Development Corp (PEY)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 25.52 |
|---|---|
| 52-week range | 19.91 – 29.22 |
| Return, 1 month / 3 months | +8.8% / −1.0% |
| Return, 1 year / 3 years | +34.0% / +125.2% |
| Trend | Uptrend |
| RSI (14) | 66 |
| Volatility (1 year) | 27.0% |
| Worst drawdown (1 year) | -18.5% |
| Average daily value traded | 16.34M CAD |
| Dividend yield | 5.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Peyto Exploration & Development Corp is a Canadian energy company that explores for, develops and produces natural gas and natural gas liquids. Its operations are concentrated in the Deep Basin area of Alberta, where it drills and operates wells and runs processing and gathering infrastructure. The company's customers are mainly buyers of natural gas and liquids, and it is based in Calgary, Alberta.
Peyto Exploration&Development Corp trades under the code PEY on the Toronto Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Peyto Exploration&Development Corp (PEY) trades on the Toronto Exchange in Canada. It last closed at CAD 25.52 on 23 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 171 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 34.0% and over the last three months it fell 1.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.5% | ||
| From 52-week high | -11.9% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.0% | ||
| 6-month return | 7.4% | ||
| 12-month return, skipping the last month | 23.2% | ||
| Stability (higher is calmer) | 75 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.5% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 16.34M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 72 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 5.4% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.4% |
|---|---|
| 1 month | +8.8% |
| 3 months | −1.0% |
| 6 months | +7.4% |
| 1 year | +34.0% |
| 3 years | +125.2% |
| 5 years | +317.1% |
Signals
| 50-day / 200-day average | 24.45 / 24.65 |
|---|---|
| Golden / death cross (60 days) | Death, 11 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.57 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Sep 2026 | CAD 0.1200 |
| 31 Aug 2026 | CAD 0.1200 |
| 31 Jul 2026 | CAD 0.1200 |
| 30 Jun 2026 | CAD 0.1200 |
| 29 May 2026 | CAD 0.1200 |
| 30 Apr 2026 | CAD 0.1100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.